Supernus Pharmaceuticals Inc. (SUPN) Financial Statements (2025 and earlier)

Company Profile

Business Address 9715 KEY WEST AVENUE
ROCKVILLE, MD 20850
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

12/31/2024
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments461,334339,680422,533347,073356,018140,040
Cash and cash equivalent93,120203,434288,640181,381192,248100,304
Short-term investments 368,214136,246133,893165,692163,77039,736
Receivables165,497148,932140,87787,332102,92265,586
Inventory, net of allowances, customer advances and progress billings91,54185,95948,32526,62825,65916,304
Inventory91,54185,95948,32526,62825,65916,304
Other undisclosed current assets15,77927,01918,68211,6118,8886,521
Total current assets:734,151601,590630,417472,644493,487228,451
Noncurrent Assets
Operating lease, right-of-use asset    21,279✕✕
Property, plant and equipment  37,82417,0684,0955,124
Long-term investments and receivables 93,896119,166350,359591,773418,798133,638
Long-term investments 93,896119,166350,359591,773418,798133,638
Intangible assets, net (including goodwill)819,482902,209442,25324,84031,36836,019
Goodwill117,019117,51677,911   
Intangible assets, net (excluding goodwill)702,463784,693364,34224,84031,36836,019
Deferred income tax assets    32,063✕✕
Other noncurrent assets39,80649,23243,249615380389
Deferred tax assets, net✕✕✕✕✕29,68320,843
Other undisclosed noncurrent assets 15,17316,955    
Total noncurrent assets:968,3571,087,562873,685687,638484,324196,013
TOTAL ASSETS:1,702,5081,689,1521,504,1021,160,282977,811424,464
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities96,342117,68378,93449,71452,10750,087
Taxes payable✕✕  2,44312,37715,938
Accounts payable    10,1413,1956,844
Accrued liabilities96,342117,68378,93437,13036,53527,305
Debt 401,968 3,7612,825  
Business combination, contingent consideration, liability21,12044,84030,900   
Other liabilities 16,86320,1329,082   
Other undisclosed current liabilities151,665132,724122,431108,048109,24672,913
Total current liabilities:687,958315,379245,108160,587161,353123,000
Noncurrent Liabilities
Long-term debt and lease obligation  420,550390,330375,610329,462 
Long-term debt, excluding current maturities  379,252361,751345,170329,462 
Liabilities, other than long-term debt128,346137,372123,8069,40911,39810,577
Deferred income tax liabilities49,80985,35535,215 ✕✕
Other liabilities8,69216,38042,7919,40911,39810,577
Operating lease, liability35,99841,29828,57930,440✕✕
Business combination, contingent consideration, liability 33,84735,63745,800   
Other undisclosed noncurrent liabilities    19,24822,57523,407
Total noncurrent liabilities:128,346557,922514,136404,267363,43533,984
Total liabilities:816,304873,301759,244564,854524,788156,984
Equity
Equity, attributable to parent886,204815,851744,858595,428453,023267,480
Common stock545353535251
Additional paid in capital408,115434,337409,332388,410369,637294,999
Accumulated other comprehensive income (loss)(3,210)1,5398,9757,417(3,158)(747)
Retained earnings (accumulated deficit)481,245379,922326,498199,54886,492(26,823)
Total equity:886,204815,851744,858595,428453,023267,480
TOTAL LIABILITIES AND EQUITY:1,702,5081,689,1521,504,1021,160,282977,811424,464

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

12/31/2024
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues667,238579,775520,397392,755408,897302,238
Revenue, net✕✕✕✕✕✕294,097
Cost of revenue(166,341)(95,920)(65,761)(16,660)(15,356)(15,215)
Cost of product and service sold(87,221)(75,061)(52,459)(16,660)(15,356)(15,215)
Gross profit:500,897483,855454,636376,095393,541287,023
Operating expenses(454,773)(397,826)(280,938)(227,524)(249,097)(187,482)
Operating income:46,12486,029173,698148,571144,44499,541
Nonoperating income (expense)14,619(12,854)(5,050)(1,084)(4,268)1,077
Investment income, nonoperating     13,8432,940
Other nonoperating income (expense)14,619(12,854)(5,050)(1,084)  
Interest and debt expense (2,416)(19,696)(19,435)(18,207)(13,840)(295)
Income from continuing operations before equity method investments, income taxes:58,32753,479149,213129,280126,336100,323
Other undisclosed income from continuing operations before income taxes 2,41619,69619,43518,20713,840295
Income from continuing operations before income taxes:60,74373,175168,648147,487140,176100,618
Income tax expense(32)(19,751)(41,698)(34,431)(29,183)(43,334)
Income from continuing operations:60,71153,424126,950113,056110,99357,284
Income before gain (loss) on sale of properties:✕✕53,424126,950113,056110,99357,284
Net income attributable to parent:60,71153,424126,950113,056110,99357,284
Other undisclosed net income available to common stockholders, basic 3,556     
Net income available to common stockholders, basic:64,26753,424126,950113,056110,99357,284
Interest on convertible debt 3,556    134
Dilutive securities, effect on basic earnings per share      32
Net income available to common stockholders, diluted:67,82353,424126,950113,056110,99357,450

Comprehensive Income ($ in thousands)
Annual | Quarterly

12/31/2024
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income:60,71153,424126,950113,056110,99357,284
Comprehensive income:60,71153,424126,950113,056110,99357,284
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(4,749)(7,436)1,55810,575(2,411)(613)
Comprehensive income, net of tax, attributable to parent:55,96245,988128,508123,631108,58256,671

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: